Skip to Content
Merck
  • Development of a multiplexed bead-based assay for detection of DNA methylation in cancer-related genes.

Development of a multiplexed bead-based assay for detection of DNA methylation in cancer-related genes.

Molecular bioSystems (2009-02-20)
Simon Corrie, Pavel Sova, Gwen Lawrie, Bronwyn Battersby, Nancy Kiviat, Matt Trau
ABSTRACT

Herein we report a method for the detection of methylated CpG dinucleotides located within CpG islands in genomic DNA using multiplexed bead-based assays and standard flow cytometry instrumentation. Four CpG "clusters" were identified in the TFPI2 and SPARC CpG islands whose methylation status was highly correlated with the incidence of invasive cervical cancer in our previous studies. Eight probes in total were designed for both the methylated and unmethylated forms of each cluster and attached to different fluorescently-encoded organosilica bead sets. Probe design was investigated by changing either the length of probes whilst keeping the melting temperature constant, or changing the melting temperature and keeping the probe length constant. Asymmetric polymerase chain reaction (PCR) methods designed without methylation-specific primers were used to prepare fluorescently-labelled targets based on bisulfite-converted genomic DNA. After investigating the specificity of the probes in a model system using fluorescently-labelled synthetic oligonucleotides, cancer cell-line DNA was analysed and the constant length probe design facilitated the correct genotyping of all clusters with respect to negative controls.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Atto 390 azide, BioReagent, suitable for fluorescence, ≥90% (HPLC)
Supelco
Atto 390 NHS ester, BioReagent, suitable for fluorescence